Wed, Sep 17, 2014, 9:41 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Keryx Biopharmaceuticals Inc. Message Board

mgm2020 1706 posts  |  Last Activity: 2 hours 15 minutes ago Member since: Mar 3, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    SEC

    by bigjeff11709 6 hours ago
    mgm2020 mgm2020 2 hours 15 minutes ago Flag

    The "crime" first occurred when the AP story was reported saying that the price drop in the morning was DUE to the "unexpected" warning from the FDA on the label, but the label wording was not revealed until just before the stock resumed trading at about 1:30. That story was then carried by other outlets and disseminated. IF there was malicious intent to damage the stock and the AP author KNEW that his story was incorrect, then THAT is manipulative and fraudulent-----and caused MILLIONS in damages to stockholders. No counterpoint or opposing view?? Very questionable intent.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 2 hours 23 minutes ago Flag

    What is wrong with you???????? The high ferritin levels seen now are DUE TO OVERTREATMENT with IV iron!!! These patients are NOT on any other supplemental iron. If doctors routinely get ferritin levels to 900 with IV iron, they will be ECSTATIC to be able to DISCONTINUE THE IV, put the patient on ferric citrate------and watch their ferritin levels DROP!

    Sentiment: Strong Buy

  • at the muscular conference within the next couple of weeks and explaining the significance----and CEO thinks the rest of the world will share their excitement. This is as close as a CEO can come to revealing key positive results as possible. Other drugs in the pipeline and other collaborations and partnerships very promising and lucrative(Astra Zeneca, GSK, Achaogen etc...). New aminoglycoside, non-Hodgekins lymphoma therapy-----and over 30 other drugs in development. Everyone here probably knows all of this----but when you hear it directly from the CEO who was extremely upbeat and enthusiastic(for an old guy) it carries a little more impact. Plenty of room to run here.

    Sentiment: Strong Buy

  • Tune in.

    Sentiment: Strong Buy

  • Call in for the lighting round and mention that. If he follows the stock he should know that.

    Sentiment: Strong Buy

  • I am very interested in what he has to say regarding the progress in antisense technology and gene silencing. If the market picks up on it---and they usually do when someone is on with Cramer, then IDRA should be able to catch some of the coattails, or even garner more interest since they are SO CHEAP relative to ISIS AND the potentially explosive growth in this biotech area. I do own stock in both.

    Sentiment: Strong Buy

  • His latest post states that IV iron use has gone UP in the last 4 years and doctors routinely get patient's ferritin levels up to 900, apparently without concern or worry. That would make ferric citrate a much better alternative since it controls the HPP AND may allow the complete discontinuation of these higher amounts of IV iron. Thanks bigbird.

    Sentiment: Strong Buy

  • His latest post states that IV iron use has gone UP in the last 4 years and doctors routinely get patient's ferritin levels up to 900, apparently without concern or worry. That would make ferric citrate a much better alternative since it controls the HPP AND may allow the complete discontinuation of these higher amounts of IV iron. Thanks bigbird.

    Sentiment: Strong Buy

  • You can also take the statements you have posted as an indication that the nephrologists are much more concerned with maintaining iron levels through ferritins and TSAT because IV iron use has gone UP during the period outlined. This would make ferric citrate a more valuable option since it will not only control the patient's HPP but ALSO eliminate the need for the ADDITIONAL IV iron dosing that, according to your data, has gone UP considerably over the last couple of years. WHY are the doctors prescribing MORE IV iron for their patients? Obviously they are NOT as concerned as you think they are, and DON'T consider these levels to be problematic at all. You JUST refuted everything you have been claiming. Thank you for showing us how much doctors will embrace ferric citrate since it will allow them to curtail the high amounts of IV iron they have been prescribing for their patients.

    Sentiment: Strong Buy

  • as ISIS, with 3rd generation antisense technology and new patented GSO's. This is a BASE if I have ever seen one, and when the breakout comes the stock could double in a matter of days------and I'm not waiting for a HIGHER price to buy!

    Sentiment: Strong Buy

  • Reply to

    nephrologycat- could you tell me

    by dalton880 Sep 16, 2014 12:32 PM
    mgm2020 mgm2020 Sep 16, 2014 1:51 PM Flag

    You are correct nephcat. Bigbird makes it sound as if the ONLY factor to consider if prescribing ferric citrate is the ferritin level PERIOD. It doesn't work that way. Ferritin levels of under 1000 are NOT considered to be problematically high in most individuals and the ferritin and TSAT will be beneficial along with stabilized hemoglobin for red blood cell formation. The vast majority of patients treated with zerenex will have ferritin levels in the 500-800 level-----PERFECTLY HEALTHY and harmless------without the need for IV iron and in many cases EPO also. Bigbird can keep spinning his posts any way that he wants, but his posts strictly pointing to the "trial results" are merely able to state the data that has been made available to the public---which is NOT the full data set that was made available to the FDA. This will also be the case for CKD where we will have limited data available but the FDA will have the complete set. The most important fallacy in all of bigbirds posts claiming high levels of ferritins and other issues with the trials-----is that the FDA APPROVED FERRIC CITRATE on the SAME DATA! What can his response to that be? That THEY misinterpreted the data---really? That they don't know a ferritin from a ferret--really? That an anonymous poster on a MB has a greater understanding of the extensive and compelling trial data than they do---really?? I don't think so. Just a fool and his short position.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Sep 16, 2014 10:46 AM Flag

    You've got to have a lot more than a screw loose to think THIS is the time to sell ACAD. With the breakthrough designation, the NDA filing within the next 12 weeks, and the LIKELIHOOD of a priority review and APPROVAL within 9 months the stock should easily DOUBLE from here BY THEN. Now is the time to be accumulating as many shares as possible after the drop from above $29/share and the stock still waiting to reclaim the previous high. Anyone selling here has a desire to fail in investing.

    Sentiment: Strong Buy

  • That is a stock that should not have the restraints that have been acting against KERX. There is NO treatment available for what their drug, Nuplazid, addresses which is Parkinson's psychosis, and they were just informed that they will be considered for breakthrough drug designation and file their NDA with 1 P3 trial---which was extremely successful. But anyone already in ACAD knows all that. Since they will be filing by the end of the year, breakthrough designation generally means an expedited review and approval, meaning their drug could be APPROVED within 9 months. The stock should double(or more) by then.

    Sentiment: Strong Buy

  • Reply to

    To My Friend MGM - Here is the 2-year Data

    by bglbfrd Sep 15, 2014 11:32 AM
    mgm2020 mgm2020 Sep 15, 2014 5:58 PM Flag

    The OLE study was a continuation of the long term P3 study. It was the P3 data that showed an increase in ferritin level an plateau through week 36 and then a drop. This data was consistent for all of the patients in the P3 study. The patients in the OLE study may not have been compensated for their time and just dropped out. The FDA had access to all of the data that we have and much more, since the application was about 100,000 pages long------and they chose to APPROVE ferric citrate with nothing other than a common-sense alert that these patients should either be off IV iron or have it reduced. That is all. Your SPIN and total negativity along with misleading people regarding "your take" on the trial results----which resulted in APPROVAL-----is what I believe is dishonest.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Sep 15, 2014 2:37 PM Flag

    I was posting in response to your cumulative posting today. and not just the original post. You must realize, though, that stock price change is not 100% analytical or predictable and some market forces cannot b accounted for on a chart such as sentiment, change of status of a company(ACAD designation as a breakthrough drug), or geopolitical changes. Just like the NFL, anything can happen on any given day---but in the end you can tell which teams(stocks) are going to be winners, losers, or in the playoffs. Good luck with your day trading and it's amazing that you've lasted this long.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Sep 15, 2014 2:08 PM Flag

    What does ANY of what you say, or how many degrees you have(and I have 3 including a BA in Biology, a BS, and a doctorate) have ANYTHIING to do with the fact that ACAD has a drug with a potential of AT LEAST $5 BILLION in annual sales that was granted a breakthrough designation and COULD be approved in as little as 9 MONTHS when they file prior to the end of the year and will be awarded expedited review? The stock still hasn't approached or surpassed it's previous high----which it will within the next few weeks(is my guess) and then once their NDA is filed will DOUBLE prior to approval(the average biotech stock increases roughly 90% in the year following it's NDA until approval) and ACAD is NO ORDINARY BIOTECH. And that is all without the prospect of a buyout at a significant premium.

    Sentiment: Strong Buy

  • KERX has had 4 previous significant dips in the last 6 months, prior to this one. Twice the stock price dipped below the 200 day moving average and in both of those cases the stock only remained below the 200 DMA for a few days before rising an average of 30% from the low. The stock has been just below the 200 DMA for the past 3 days and is brushing right up against it. Once it moves back above, the average will again act as support as it did back in May following the delay announcement when it rose over 35% from the bottom before there was another dip. Now we have the approval or ferric citrate, and a stock that has dropped 25% on a meaningless "warning"(benefit) for the doctors who will be prescribing it and the patients who will be appropriately monitored by their doctors exactly the same way they were before. The launch is coming up in about 10 weeks and when the company announces the first inclusion by insurance panels and the pricing the stock will see a significant jump. That could be announced any day. The shorts on the board are trying their best to continue to post their deceptive garbage and I'm sure they will continue, even as the stock price begins to rise back up. But all you have to do is go back and read the PR's and CC transcripts to reassure yourself of the benefits and advantages of ferric citrate for doctors and patients and the reasons you are in the stock, and none of that has changed------oh---one thing has changed------IT IS APPROVED! Sales coming and acceptance by the medical community will be very positive.

    Sentiment: Strong Buy

  • Reply to

    Clearly Up Other's False Statement re P3 Data

    by bglbfrd Sep 15, 2014 2:50 AM
    mgm2020 mgm2020 Sep 15, 2014 8:28 AM Flag

    You can "post" whatever you want but the data di show over the 2 years of the OLE study that ferritin levels rose and plateaued up until week 36 AND THEN DECREASED. Reread the PR's and the data and stop posting your deceptive and lying nonsense. If the Japanese were that worried about ferritin levels over 500(and you can just admit that you made that up) then WHY did they approve the drug knowing ALL of the trial data? Why do you think that no one here understands this drug and has read and studied all of the trial data? You are just a CLOWN----and I think you are spill trying to sound like someone else-----but you are both full of it.

    Sentiment: Strong Buy

  • mgm2020 mgm2020 Sep 14, 2014 9:38 PM Flag

    So you obviously agree then that you are indeed one of the IDIOTS! That's too funny!! But you are right!

    Sentiment: Strong Buy

  • Reply to

    NO binary events this year...

    by ranger43a Sep 13, 2014 12:27 PM
    mgm2020 mgm2020 Sep 14, 2014 9:33 PM Flag

    Waldenstrom's would be nice feather in the cap, and when the first set of positive revealed data is released the stock should have a very nice pop--from wherever it is at the time(hopefully a bit higher than here). But Waldenstrom's is usually considered a condition that you will die WITH and not from, and there are a few companies working on therapies for WM. I think the mother lode is going to be dermatomyositis and polymyositis as well as GVH. The myositis's are true orphan diseases with ineffective treatments and many suffering patients. The trials for these conditions could even be halted early for efficacy and that's really when things will start to go crazy. I am going to enjoy the ride higher a la ISIS and hope we reach those levels at some point in the next couple of years.

    Sentiment: Strong Buy

KERX
13.69+0.14(+1.03%)Sep 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.